Product logins

Find logins to all Clarivate products below.


The Cybercitizen Health® Europe 2014 survey was fielded in Q3 of 2014. In total, 3018 adults (age 18 and over) were surveyed in these countries: the United Kingdom (n=606), France (n=604), Germany (n=601), Italy (n=604) and Spain (n=603). The survey was conducted online, and consumers were told it was regarding research on their use of the internet and other communication tools. The survey instrument was presented and completed in the native language within each market. The respondents in this research are reflective of the online population with the target audiences within Europe today.

Related Multichannel Engagement Reports

Report
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | Pneumococcal Vaccines
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | Pneumococcal Vaccines Our 2023 study among patients and caregivers provides detailed insights and recommendations on the…
Report
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | HPV Vaccines
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | HPV Vaccines Our 2023 study among patients and caregivers provides detailed insights and recommendations on the information-…
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | Colombia | Segmentation
Patient Multichannel Insights | 2022 | Cybercitizen Health | Colombia (Segmentation Data Tables)
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | Multiple Myeloma | Segmentation
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | Multiple Myeloma (Segmentation Data Deck)
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | AML VS CLL VS MM | Segmentation Data
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | AML VS CLL VS MM (Segmentation Data Comparison Table)